[1] Preiss D, Sattar N. Pharmacotherapy: Statins and new-onset diabetes--the important questions. Nat Rev Cardiol. 2012;9(4): 190-192. [2] Tan DA. Changing disease trends in the Asia-Pacific. Climacteric. 2011;14(5):529-534. [3] Maeda H, Hanazaki K. Pancreatogenic diabetes after pancreatic resection. Pancreatology. 2011;11(2):268-276. [4] Lehach EI, Bodnar Iu I, Bozhok HA. Prophylaxis of a specific type diabetes mellitus development using pancreatic insuli autotranspiantation after pancreatic resection. Klin Khir. 2011; (12):63-67. [5] Guan ZA, Sun MX, Guan DS, et al. Tianjin: Tianjin Kexue Jishu Chubanshe. 2001.关子安,孙茂欣,关大顺,等.现代糖尿病学[M].天津:天津科学技术出版社,2001. [6] Du GH, Li XJ, Zhang YX, et al. Beijing Science Press. 2001.杜冠华,李学军,张永祥,等.药理学实验指南-新药发现和药理学评价[M].北京:科学出版社,2001.[7] Jaidane H, Sane F, Gharbi J, et al. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev. 2009;25(7):591-603. [8] Colli ML, Nogueira TC, Allagnat F, et al. Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim/Mcl-1 imbalance. PLoS Pathog. 2011;7(9):e1002267. [9] Sauter P, Hober D. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes and infection/Institut Pasteur. 2009;11 (4):443-451. [10] Diz R, Garland A, Vincent BG, et al. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. PLoS One. 2012;7(12):e52054. [11] Bortell R, Yang C. The BB rat as a model of human type 1 diabetes. Methods Mol Biol. 2012;933:31-44. [12] Zhao YY, Huang XY, Chen ZW. Daintain/AIF-1 (Allograft Inflammatory Factor-1) accelerates type 1 diabetes in NOD mice. Biochem Biophys Res Commun. 2012;427(3):513-517. [13] Grant CW, Duclos SK, Moran-Paul CM, et al. Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes. Comp Med. 2012;62(5): 381-390. [14] Wu J, Kakoola DN, Lenchik NI, et al. Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetes. PLoS One. 2012;7(10):e46941. [15] Wszola M, Berman A, Fabisiak M, et al. TransEndoscopic Gastric SubMucosa Islet Transplantation (eGSM-ITx) in pigs with streptozotocine induced diabetes-technical aspects of the procedure - preliminary report. Ann Transplant. 2009; 14(2):45-50. [16] Strauss A, Moskalenko V, Tiurbe C, et al. Goettingen Minipigs (GMP): Comparison of Two Different Models for Inducing Diabetes. Diabetol Metab Syndr. 2012;4(1):7.[17] Szkudelski T. Themechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6): 537-546. [18] Liu YQ, Li CH, Chen H. Shiyan Dongwu Kexue. 2007;24(5): 24-26.刘亚千,李春海,陈华.三个品系实验用小型猪部分血液生化指标比较[J].实验动物科学,2007,24(5):24-26. [19] Chen H. Zhongguo Shiyan Dongwu Xuebao. 2009;16(6): 458-462.陈华.小型猪糖尿病模型[J].中国实验动物学报,2009,16(6): 458-462. [20] Dutta T, Chai HS, Ward LE, et al. Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes. 2012;61(5):1004-1016. [21] Yu X, Park BH, Wang MY, et al. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A. 2008;105(37):14070-14075. [22] Galan M, Kassan M, Choi SK, et al. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus. Hypertension. 2012;60(1):71-80. [23] Gunawardana SC, Piston DW. Reversal of type 1 diabetes in mice by Brown adipose tissue transplant. Diabetes. 2012; 61(3):674-682. [24] Dufrane D, van Steenberghe M, Guiot Y, et al. Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and [beta]-cell Plasticity. Transplantation. 2006;81(1):36-45. [25] Jensen-Waern M, Andersson M, Kruse R, et al. Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism. Lab Anim. 2009;43(3):249-254. [26] Von Wilmowsky C, Stockmann P, Metzler P, et al. Establishment of a streptozotocin-induced diabetic domestic pig model and a systematic evaluation of pathological changes in the hard and soft tissue over a 12-month period. Clin Oral Implants Res. 2010;21(7):709-717.[27] Lee PY, Park SG, Kim EY, et al. Proteomic analysis of pancreata from mini-pigs treated with streptozotocin as a type I diabetes models. J Microbiol Biotechnol. 2010;20(4): 817-820. [28] Hara H, Lin YJ, Zhu X, et al. Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas. 2008;36(1):31-38. [29] Wang YT, Wang ZB. Zhongguo Bijiao Yixue Zazhi. 2012;21 (12):70-73.王月婷,王宗保.小型猪糖尿病模型研究进展[J].中国比较医学杂志,2012,21(12):70-73. [30] Aschenbach J, Steglich K, Gäbel G, et al. Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs. J Physiol Biochem. 2009;65(3): 251-266. [31] Freitas HS, Schaan BD, Seraphim PM, et al. Acute and short-term insulin-induced molecular adaptations of GLUT2 gene expression in the renal cortex of diabetic rats. Mol Cell Endocrinol. 2005;237(1-2):49-57. [32] Goestemeyer A, Marks J, Srai S, et al. GLUT2 protein at the rat proximal tubule brush border membrane correlates with protein kinase C (PKC)-βl and plasma glucose concentration. Diabetologia. 2007;50(10):2209-2217. [33] Park S-K, Haase VH, Johnson RS. von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase. Int J Oncology. 2007;30(2):341-348. [34] Schmidt C, Höcherl K, Bucher M. Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol. 2007;292(2):F804-F11. [35] The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.[36] Strauss A, Tiurbe C, Chodnevskaja I, et al. Use of the continuous glucose monitoring system in Goettingen Minipigs, with a special focus on the evaluation of insulin-dependent diabetes. Transplant Proc. 2008;40(2):536-539. [37] Ludvigsson J. C-peptide in diabetes diagnosis and therapy. Front Biosci (Elite Ed). 2013;5:214-223. [38] Wang S, Wei W, Zheng Y, et al. The role of insulin c-peptide in the coevolution analyses of the insulin signaling pathway: a hint for its functions. PLoS One. 2012;7(12):e52847. [39] Wang Z, Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes. 1998;47(1):50-56. [40] Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Ann Rev Physiol. 2012;74:351-375.[41] Kramer J, Moeller EL, Hachey A, et al. Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates. Am J Physiol Regul Integr Comp Physiol. 2009;296(3):R786-R793. |